| Raymond Little, MD | |
|
24040 Highway 59 N, Kingwood, TX 77339-1500 | |
| (281) 312-0242 | |
| Not Available |
| Full Name | Raymond Little |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 32 Years |
| Location | 24040 Highway 59 N, Kingwood, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669485546 | NPI | - | NPPES |
| 1550047 | Other | AETNA | |
| 8AA750 | Other | BLUECROSS BLUESHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | L0854 (Texas) | Primary |
| Entity Name | North Houston Heart And Vascular Associates, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275759243 PECOS PAC ID: 8729175807 Enrollment ID: O20071106000764 |
News Archive
Oramed Pharmaceticals, Inc., a developer of oral drug delivery systems, announced today that it has received approval from the Institutional Review Board (IRB) to commence human clinical trials of an oral GLP-1 Analog.
Orchid Cellmark Inc., a leading international provider of identity DNA testing services, today reported its financial results for the fourth quarter and full year of 2009.
Celiac disease (CD) is an inherited intestinal disorder characterized by life-long intolerance to the ingestion of gluten, a protein found in wheat, rye, and barley. Although CD can be diagnosed at any age, it commonly occurs during early childhood (between 9 and 24 months). Reduced bone mineral density is often found in individuals with CD.
UK regulators have approved Europe's first clinical trial of a monoclonal antibody produced from genetically modified plants. This landmark decision sets the stage for the testing, in humans, of an anti-HIV product made from genetically modified tobacco plants. It will open the door for trials of additional plant-derived medicines treating a range of diseases.
H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. announced today the continuation of the development program of Lu AE58054 for the treatment of Alzheimer's disease, initiating the first out of four phase III clinical trials with the compound.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Raymond Little, MD 24040 Highway 59 N, Kingwood, TX 77339-1500 Ph: (281) 312-0242 | Raymond Little, MD 24040 Highway 59 N, Kingwood, TX 77339-1500 Ph: (281) 312-0242 |
News Archive
Oramed Pharmaceticals, Inc., a developer of oral drug delivery systems, announced today that it has received approval from the Institutional Review Board (IRB) to commence human clinical trials of an oral GLP-1 Analog.
Orchid Cellmark Inc., a leading international provider of identity DNA testing services, today reported its financial results for the fourth quarter and full year of 2009.
Celiac disease (CD) is an inherited intestinal disorder characterized by life-long intolerance to the ingestion of gluten, a protein found in wheat, rye, and barley. Although CD can be diagnosed at any age, it commonly occurs during early childhood (between 9 and 24 months). Reduced bone mineral density is often found in individuals with CD.
UK regulators have approved Europe's first clinical trial of a monoclonal antibody produced from genetically modified plants. This landmark decision sets the stage for the testing, in humans, of an anti-HIV product made from genetically modified tobacco plants. It will open the door for trials of additional plant-derived medicines treating a range of diseases.
H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. announced today the continuation of the development program of Lu AE58054 for the treatment of Alzheimer's disease, initiating the first out of four phase III clinical trials with the compound.
› Verified 7 days ago
Liza Jemison, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1330 Kingwood Dr, Suite 200, Kingwood, TX 77339 Phone: 281-348-7301 Fax: 281-348-2186 | |
Dr. Mohamed Wael J Khirfan, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 24044 Highway 59 N, Kingwood, TX 77339 Phone: 281-674-7812 Fax: 281-310-6602 | |
Dr. Sivatej Sarva, M.B.B.S Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 451 Kingwood Medical Dr Ste 100, Kingwood, TX 77339 Phone: 281-318-2043 Fax: 281-536-6306 | |
Branden Carl Wilson, DO Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 22999 Highway 59 N Ste 105, Kingwood, TX 77339 Phone: 281-348-8934 | |
Dr. Syed Arman Raza, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2627 Chestnut Ridge Dr, Suite 100, Kingwood, TX 77339 Phone: 281-358-1950 Fax: 281-358-3102 | |
Dr. Mary K Crow, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 22710 Professional Dr, Kingwood, TX 77339 Phone: 281-298-8444 Fax: 281-298-7720 | |
Mr. Alexander Tiu, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 22999 Highway 59 N, # 214, Kingwood, TX 77339 Phone: 281-359-5010 Fax: 281-359-5131 |